Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01978457 · ClinicalTrials.gov registry record · Phase 1
Establishing and Eliminating Cue-drug Associations in Human Cocaine Addiction
A Phase 1 study, sponsored by Yale University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT01978457 is a Phase 1 study that was terminated before completion, run by Yale University. The registered enrollment target is 6 participants.
The verdict
NCT01978457, a Phase 1 study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
We will develop a procedure for conditioning cue-cocaine associations in human drug users. Next, we will reactivate that learning and intervene pharmacologically to prevent the reconsolidation of cue-drug memories. We hypothesize that a combined behavioral and pharmacological approach will have significant potential for persistently inhibiting relapse.
Interventions
- DRUG placebo
- DRUG propranolol
- DRUG cocaine hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2012-10 |
| Est. Completion | 2019-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01978457
The ClinicalTrials.gov registry entry for NCT01978457 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT01978457 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01978457 about?
NCT01978457 is a clinical study titled "Establishing and Eliminating Cue-drug Associations in Human Cocaine Addiction". We will develop a procedure for conditioning cue-cocaine associations in human drug users. Next, we will reactivate that learning and intervene pharmacologically to prevent the reconsolidation of cue-drug memories. We hypothesize that a combined behavioral and pharmacological approach will have sign...
What is the current status of trial NCT01978457?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2012-10. Estimated completion is 2019-12.
What interventions are being tested in trial NCT01978457?
The interventions under investigation include: placebo (DRUG), propranolol (DRUG), cocaine hydrochloride (DRUG).
Who is sponsoring clinical trial NCT01978457?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.